Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Regulatory Pathway and Timeline Expectations The FDA Reauthorization Act (FDARA) of 2017 requires sponsors to submit a Pediatric Study Plan (PSP) for any new molecular entity expected to be used in patients under 18 [6]
Mandel SA, Amit T, et al
In this guide, you will learn: What are the eligibility rules in simple terms How each countrys process works and what challenges you might face What are the most common safety concerns and side effects
Expression and localization of prostaglandin transporter in Alzheimer disease brains and age-matched controls
US$ 26.93
US$ 20.93
US$ 25.10
US$ 27.35
US$ 27.48
US$ 24.38
US$ 20.73
